Stories
Slash Boxes
Comments

SoylentNews is people

SoylentNews is powered by your submissions, so send in your scoop. Only 16 submissions in the queue.
posted by cmn32480 on Thursday November 02 2017, @04:11PM   Printer-friendly
from the it-cures-everything dept.

The U.S. Food and Drug Administration is warning four companies that sell products containing cannabidiol (CBD) to stop making unsubstantiated health claims, such as "combats tumor and cancer cells":

The FDA has grown increasingly concerned at the proliferation of products claiming to treat or cure serious diseases like cancer. In this case, the illegally sold products allegedly contain cannabidiol (CBD), a component of the marijuana plant that is not FDA approved in any drug product for any indication. CBD is marketed in a variety of product types, such as oil drops, capsules, syrups, teas, and topical lotions and creams. The companies receiving warning letters distributed the products with unsubstantiated claims regarding preventing, reversing or curing cancer; killing/inhibiting cancer cells or tumors; or other similar anti-cancer claims. Some of the products were also marketed as an alternative or additional treatment for Alzheimer's and other serious diseases.

The companies in question are Greenroads Health, Natural Alchemist, That's Natural! Marketing and Consulting, and Stanley Brothers Social Enterprises LLC.

Also at Bloomberg, The Cannabist, The Hill, NBC, and Newsweek.

Related: U.S. Federal Cannabis Prohibition Remains Intact
"Hollyweed" and More Cannabis Stories
According to Gallup, American Support for Cannabis Legalization is at an All-Time High
Study Finds That More Frequent Use of Cannabis is Associated With Having More Sex


Original Submission

 
This discussion has been archived. No new comments can be posted.
Display Options Threshold/Breakthrough Mark All as Read Mark All as Unread
The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way.
  • (Score: 2) by takyon on Thursday November 02 2017, @05:41PM

    by takyon (881) <takyonNO@SPAMsoylentnews.org> on Thursday November 02 2017, @05:41PM (#591182) Journal

    https://en.wikipedia.org/wiki/Controlled_Substances_Act [wikipedia.org]

    The legislation created five Schedules (classifications), with varying qualifications for a substance to be included in each. Two federal agencies, the Drug Enforcement Administration (DEA) and the Food and Drug Administration (FDA), determine which substances are added to or removed from the various schedules, although the statute passed by Congress created the initial listing.

    [...] Schedule I substances are described as those that have the following findings:

    1. The drug or other substance has a high potential for abuse.
    2. The drug or other substance has no currently accepted medical use in treatment in the United States.
    3. There is a lack of accepted safety for use of the drug or other substance under medical supervision.
    --
    [SIG] 10/28/2017: Soylent Upgrade v14 [soylentnews.org]
    Starting Score:    1  point
    Karma-Bonus Modifier   +1  

    Total Score:   2